Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Acadia Pharmaceutica (ACAD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,755,320
  • Shares Outstanding, K 143,882
  • Annual Sales, $ 223,810 K
  • Annual Income, $ -245,190 K
  • 60-Month Beta 3.30
  • Price/Sales 17.50
  • Price/Cash Flow N/A
  • Price/Book 7.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.54
  • Number of Estimates 5
  • High Estimate -0.50
  • Low Estimate -0.57
  • Prior Year -0.44
  • Growth Rate Est. (year over year) -22.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.61 +15.83%
on 02/27/19
28.12 -6.86%
on 03/14/19
+2.44 (+10.27%)
since 02/25/19
3-Month
14.33 +82.76%
on 12/26/18
28.12 -6.86%
on 03/14/19
+11.87 (+82.89%)
since 12/24/18
52-Week
12.77 +105.09%
on 08/09/18
28.12 -6.86%
on 03/14/19
+3.62 (+16.04%)
since 03/23/18

Most Recent Stories

More News
52.7% Return Seen to Date on SmarTrend Acadia Pharmaceu Call (ACAD)

SmarTrend identified an Uptrend for Acadia Pharmaceu (NASDAQ:ACAD) on January 7th, 2019 at $17.85. In approximately 2 months, Acadia Pharmaceu has returned 52.72% as of today's recent price of $27.26....

ACAD : 26.19 (+0.34%)
Acadia Pharmaceu Falls 2.66% on Heavy Volume: Watch For Potential Rebound

Acadia Pharmaceu (NASDAQ:ACAD) traded in a range yesterday that spanned from a low of $25.95 to a high of $26.42. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of...

ACAD : 26.19 (+0.34%)
ACADIA Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference on March 11, 2019

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central...

ACAD : 26.19 (+0.34%)
Acadia Pharmaceu Has Returned 51.2% Since SmarTrend Recommendation (ACAD)

SmarTrend identified an Uptrend for Acadia Pharmaceu (NASDAQ:ACAD) on January 7th, 2019 at $17.85. In approximately 2 months, Acadia Pharmaceu has returned 51.20% as of today's recent price of $26.99....

ACAD : 26.19 (+0.34%)
SmarTrend Watching for Potential Pullback in Shares of Acadia Pharmaceu After 1.25% Gain

Acadia Pharmaceu (NASDAQ:ACAD) traded in a range yesterday that spanned from a low of $26.79 to a high of $27.17. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high...

ACAD : 26.19 (+0.34%)
ACADIA Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

--- Full Year 2018 Net Sales Grew to $223.8 Million, a 79% Increase Over Full Year 2017

ACAD : 26.19 (+0.34%)
ACADIA Pharmaceuticals to Present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central...

ACAD : 26.19 (+0.34%)
What's in the Cards for Bausch Health (BHC) Q4 Earnings?

Investors are looking forward to Salix and Bausch+Lomb's performance, and other pipeline updates when Bausch (BHC) reports Q4 results on Feb 20.

ACAD : 26.19 (+0.34%)
MNK : 21.62 (-2.13%)
BHC : 24.14 (-2.23%)
REPH : 6.41 (-34.04%)
5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings

Let us take a look at five favorable stocks, poised to beat estimates this earnings season.

PBYI : 39.46 (+1.10%)
LLY : 129.87 (+1.22%)
ACAD : 26.19 (+0.34%)
PCRX : 37.99 (-0.60%)
REPH : 6.41 (-34.04%)
EPZM : 11.60 (+1.40%)
BMY : 47.49 (-1.39%)
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on February 26, 2019

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central...

ACAD : 26.19 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade ACAD with:

Business Summary

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104...

See More

Key Turning Points

2nd Resistance Point 27.31
1st Resistance Point 26.75
Last Price 26.19
1st Support Level 25.58
2nd Support Level 24.97

See More

52-Week High 28.12
Last Price 26.19
Fibonacci 61.8% 22.26
Fibonacci 50% 20.44
Fibonacci 38.2% 18.63
52-Week Low 12.77

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar